When was Kineta, Inc. stock made available for the first time to the public?

The IPO Date for Kineta, Inc. is 2016-02-11. On this 2016-02-11, Kineta, Inc. stock was made publicly available.

Where is the headquarters of Kineta, Inc. stock?

Headquarters of Kineta, Inc. is in US at 219 Terry Ave. N, Seattle, WA 98109.

What industry does Kineta, Inc. belong to?

The Kineta, Inc. belongs to Biotechnology.

Kineta, Inc.

KA•NASDAQ

Healthcare

Biotechnology

$0.57

$-0.26(-30.77%)

Kineta, Inc. (KA) Company Profile & Overview

Explore Kineta, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Kineta, Inc. (KA) Company Profile & Overview

Kineta, Inc., a clinical stage biotechnology company, develops immunotherapies for oncology, neuroscience, and biodefense. It serves private, government, and industry partners. The company has strategic partnerships with Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Kineta, Inc. was formerly known as Lecura, Inc. The company was incorporated in 2007 and is based in Seattle, Washington.

SectorHealthcare

IndustryBiotechnology

CEOCraig W. Philips

Contact Information

https://kinetabio.com

206 378 0400

219 Terry Ave. N, Seattle, WA, 98109

Company Facts

11 Employees

IPO DateFeb 11, 2016

CountryUS

Frequently Asked Questions

;